Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/12860
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.date.accessioned2023-02-28T15:03:11Z-
dc.date.available2023-02-28T15:03:11Z-
dc.date.issued2022-09-
dc.identifier.urihttps://ninho.inca.gov.br/jspui/handle/123456789/12860-
dc.publisherINCApt_BR
dc.subjectRadioterapia (Especialidade)pt_BR
dc.subjectRadiation Oncologypt_BR
dc.subjectOncología por Radiaciónpt_BR
dc.subjectSouhami, Luispt_BR
dc.subjectNeoplasias Encefálicaspt_BR
dc.subjectBrain Neoplasmspt_BR
dc.subjectNeoplasias Encefálicaspt_BR
dc.subjectReisner, Rachele Grazziotinpt_BR
dc.titleRadioterapia do HC I recebe pesquisador considerado referência mundial em câncerpt_BR
dc.title.alternativeInforme INCA 423pt_BR
dc.TypeArticlept_BR
Appears in Collections:Informe INCA 423

Files in This Item:
File Description SizeFormat 
Informe-INCA-2022-423-4-Radioterapia-do-HCI.pdf221.55 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.